RPSA, also known as 37LRP, was upregulated in the resistant breast cancer patient, and regarding its role in drug resistance, studies by Sun et al. have shown MGr1-Ag/37LRP confer drug resistance through FAK/PI3K and MAPK mediated pathway in gastric cancer [65]. The gene discussed is RENBP; the disease is breast carcinoma.